[Allogenic bone marrow transplantation].
Yamane T, Im T, Nakao T, Kumura T, Tatsumi N.
Rinsho Byori. 1995 Jul;Suppl 99:15-23.
Bone marrow transplantation.
Wujcik D, Downs S.
Crit Care Nurs Clin North Am. 1992 Mar;4(1):149-66.
Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, Griscelli C, Fischer A.
Blood. 1995 Jun 1;85(11):3328-33.
Allogenic bone marrow transplantation or chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach.
Hertenstein B, Heil G, Heimpel H.
Ann Hematol. 1996 Apr;72(4):223-30. doi: 10.1007/s002770050164.
Allogenic bone marrow transplantation for leukemias and aplastic anemia.
Tsai TW, Freytes CO.
Adv Intern Med. 1997;42:423-51.
The application of bone marrow transplantation to the treatment of genetic diseases.
Parkman R.
Science. 1986 Jun 13;232(4756):1373-8. doi: 10.1126/science.3520819.
Allogeneic bone marrow transplantation.
Tabbara IA.
South Med J. 1996 Sep;89(9):857-68. doi: 10.1097/00007611-199609000-00003.
[Post-vaccination immunity after allogenic and autologous bone marrow transplantation].
Skovránková J.
Cas Lek Cesk. 1999 May 10;138(10):298-300.
[Bone marrow transplantation].
Speck B, Gratwohl A, Tichelli A, Nissen C.
Schweiz Med Wochenschr. 1995 Aug 19;125(33):1515-32.
Optimizing the composition of bone marrow for allogenic transplantation.
Champlin R.
J Hematother. 1995 Feb;4(1):53-60. doi: 10.1089/scd.1.1995.4.53.
